In addition, the metabolite classifier also showed great diagnostic performance with an AUC of 0.96 in differentiating AFP(−) T2DM(+) HCC patients from T2DM individuals, and the corresponding sensitivity and specificity values were 96% and 83.33%, respectively (Figure 8C,F and Table 6). This evidence concerns the gene AFP and hepatocellular carcinoma.